Articles in Health – women
FDA Advisory Panel to Discuss Safety of Transvaginal Mesh
Bloomberg reports that transvaginal mesh lawsuits are on the rise, and that a two-day hearing on their safety and effectiveness will begin tomorrow. An advisory panel “won’t take any formal votes,” but the “FDA will poll the panel of researchers and physicians on whether to reclassify the devices and gather thoughts on how to conduct clinical studies.”
College Student Who Died From Prescribed Yaz Profiled by CBS Early Show
The CBS Early Show interviewed Joan Cummins, the mother of Michelle Pfleger who died last year while walking to her morning class at college.
FDA Expands Safety Review of Yaz, Gianvi, Yasmin, Ocella and other Birth Control Drugs
As part of its ongoing safety assessment of birth control pills, the Food and Drug Administration (FDA) announced on May 31, 2011, that is reviewing two newly published studies on the risk of blood clots in women who use birth control pills that contain drospirenone.
Yaz Birth Control Pill Dangers: Death of 18-year College Student Leads to Yaz Lawsuit
Last September, Michelle Pfleger was walking to her morning class at Elon University in North Carolina when she suddenly collapsed. Michelle was taken to a nearby hospital, but despite the efforts of the medical professionals, she died.
Yaz, Yasmin: Medical Evidence of Greater Danger of Blood Clots Mounts
Two new studies show that women who take birth control pills with the newer hormone drospirenone, including Bayer HealthCare Pharmaceuticals Inc.’s Yasmin and Yaz, have a three-fold higher risk of developing potentially serious blood clots than women who take oral contraceptives containing the older hormone levonorgestrel.
Long-Term Use of Osteoporosis Drugs and Increased Risk of Fractures
In February 2011, the JAMA published a study finding that long-term osteoporosis treatment with bisphosphonates increases the risk of rare femur fractures
Bayer Healthcare To Launch New Birth Control Pill Amid Controversy Over Yaz Oral Contraceptive
Bayer to release new birth control drug called Natazia.
Bayer Healthcare Pharmaceuticals Inc. to Update Yaz & Yasmin Warning Label
Bayer Healthcare Pharmaceuticals has agreed to change its warning labels on their oral contraceptive drugs Yaz and Yasmin to alert users to the risks of developing blood clots while using the oral contraceptives.
Mother Charges Yaz Birth Control Pill Killed Her College Student Daughter
In January 2010, Leah Mayfield was rushed to the hospital after passing out in the shower. Less than an hour later she was dead. The official cause of death was pulmonary embolism, a blood clot in the lungs. The emergency room physician informed Leah’s mother that that Yaz, a birth control pill prescribed to Leah, could have caused the blood clot.
Breast Cancer and Link to Hormone-Replacement Therapy Drugs: Trial Updates
A Philadelphia jury returned a $28 million punitive damages verdict Monday against two drugmakers over the drugmakers’ hormone-replacement therapy drugs that the jury found caused a plaintiff’s breast cancer
